DNA origami as a nanomedicine for targeted rheumatoid arthritis therapy through reactive oxygen species and nitric oxide scavenging
Abstract
High levels of reactive oxygen species (ROS) and nitric oxide (NO) generated by M1 macrophages induce inflammation in the development of rheumatoid arthritis (RA). The eliminating of ROS and NO therefore represents an alternative strategy for RA treatment. Because DNA molecules possess ROS- and endogenous NO-scavenging capability, herein, we develop a nanomedicine based on triangular DNA origami nanostructures for targeted RA treatment. We showed that folic acid-modified triangular DNA origami nanostructures (FA-tDONs) could reduce ROS and NO simultaneously inside proinflammatory M1 macrophages, leading to their polarization into anti-inflammatory M2 subtype. Further in vivo studies confirmed that FA-tDONs could actively target inflamed joints in collagen-induced arthritis (CIA) mice, attenuate inflammatory cytokines and alleviate disease progression. This work demonstrated that DNA origami itself could act as a potential nanomedicine for targeted RA treatment.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synergistic Modulation of Macrophages by Methotrexate and RELA siRNA Folate-Liposome: A Precision Therapy to Prevent Joint Degradation in Collagen-Induced Arthritic Rats
Simran Nasra, Dhiraj Bhatia, Ashutosh Kumar·bioRxiv·Jan 3, 2024
- Orally administered antigen can reduce or exacerbate pathology in an animal model of inflammatory arthritis dependent upon the timing of administration
G. R. Meehan, I. B. McInnes, … P. Garside·bioRxiv·Jan 7, 2022
- TREM2 agonist antibody rebuilds the resident synovial macrophage lining barrier in rheumatoid arthritis
Huihui Yuan, Jingyun Wang, … Xiaodan Sun·bioRxiv·Feb 5, 2026
- CAR-macrophage immunotherapy targeting fibroblast-like synoviocytes ameliorates inflammatory and degenerative arthritis
Yangli Xu, Zhuqian Wang, … Chao Liang·bioRxiv·Oct 28, 2026
- Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide
Anthony Rosa, Alessia Raneri, … Linda Avesani·bioRxiv·Mar 27, 2026
- Targeting activated macrophages intracellular milieu to augment anti-inflammatory drug potency
V. M. Gouveia, L. Rizzello, … G. Battaglia·bioRxiv·Jun 22, 2021